Martin Gertsch joined ESBATech as the CFO in February 2007. He is a seasoned Chief Financial Officer and management consultant with extensive experience in working with rapidly growing companies. As a senior financial professional Martin Gertsch chairs the audit committee of the Board of Directors of Santhera Pharmaceuticals Holding AG, a Swiss Biotech company with a recent successful IPO on the Swiss Stock Exchange.
